F6Publishing

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Articles Published Processes

Keyword: Hepatic encephalopathy

Page 1 of 2 ( 100 items )
<<
1
2
>>

1	Minimal hepatic encephalopathy in hepatosplenic schistosomiasis: High prevalence and association with portosystemic shunts in a Brazilian cross-sectional study 12/26/2025 10:27:29 AM \| Browse: 15 \| Download: 88
2	Targeting gut microbiota in liver disease: A pharmacological approach for hepatic encephalopathy and beyond 12/5/2025 11:28:03 AM \| Browse: 25 \| Download: 84
3	Elevated body mass index as a prognostic marker in acute liver failure: Implications from a two-decade cohort 12/5/2025 6:43:30 AM \| Browse: 23 \| Download: 70
4	Management of acute liver failure-an updated literature review 11/28/2025 2:00:44 PM \| Browse: 28 \| Download: 75
5	Improved clinical outcomes following embolization of extrahepatic portosystemic shunts in cirrhotic patients with recurrent hepatic encephalopathy 10/27/2025 10:57:51 AM \| Browse: 144 \| Download: 163
6	Microbiome and gut-liver interactions: From mechanisms to therapies 10/27/2025 8:08:12 AM \| Browse: 107 \| Download: 131
7	Body mass index and its association with clinical outcomes in acute liver failure 10/11/2025 9:30:02 AM \| Browse: 38 \| Download: 116
8	Critical flicker frequency improves after alcohol detoxification and is associated with liver stiffness 9/19/2025 7:57:22 AM \| Browse: 324 \| Download: 87
9	Paradigm shifts in hepatic encephalopathy: A review of recent therapeutic breakthroughs 9/10/2025 8:40:29 AM \| Browse: 296 \| Download: 107
10	Risk factors for hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in cirrhotic patients: A comprehensive minireview 8/27/2025 9:21:14 AM \| Browse: 165 \| Download: 230
11	Modulating nuclear factor erythroid 2-related factor 2 and heme oxygenase-1 in liver-brain axis disorders 8/26/2025 10:18:28 AM \| Browse: 73 \| Download: 132
12	Acute liver failure etiology, clinical manifestation and outcomes in adults: Experience of tertiary care hospital in Karachi 7/18/2025 3:29:25 PM \| Browse: 57 \| Download: 368
13	Human albumin infusion for reducing hyponatremia and circulatory dysfunction in liver cirrhosis: A meta-analysis update 6/26/2025 7:27:59 AM \| Browse: 59 \| Download: 492
14	Importance of comprehensive nutritional assessment in predicting survival in cirrhosis 5/27/2025 7:04:45 AM \| Browse: 7 \| Download: 12
15	Incidence and efficacy of strategies for preventing hepatic encephalopathy following transjugular intrahepatic portosystemic shunt: A meta-analysis 4/25/2025 8:23:03 AM \| Browse: 74 \| Download: 341
16	Management of hepatic encephalopathy following transjugular intrahepatic portosystemic shunts: Current strategies and future directions 4/18/2025 7:43:23 AM \| Browse: 144 \| Download: 460
17	Effect of portal pressure gradient reduction on outcomes after transjugular intrahepatic portosystemic shunt in portal hypertension patients 3/26/2025 4:06:57 AM \| Browse: 86 \| Download: 591
18	Dysregulation of bile acid signal transduction causes neurological dysfunction in cirrhosis rats 3/26/2025 4:06:51 AM \| Browse: 72 \| Download: 530
19	Clinical features and risk factors for combined Klebsiella pneumoniae infection in patients with liver cirrhosis 2/20/2025 8:40:36 AM \| Browse: 101 \| Download: 386
20	Which patients benefit the most? An update on transjugular intrahepatic portosystemic shunt 2/20/2025 8:39:23 AM \| Browse: 90 \| Download: 424
21	Gut microbiome composition in patients with liver cirrhosis with and without hepatic encephalopathy: A systematic review and meta-analysis 1/6/2025 8:47:54 AM \| Browse: 77 \| Download: 562
22	Gut microbiota shifts in hepatitis B-related portal hypertension after transjugular intrahepatic portosystemic shunt: Mechanistic and clinical implications 12/20/2024 3:53:46 AM \| Browse: 145 \| Download: 641
23	Insights and future directions in studying intestinal microbiota post-transjugular intrahepatic portosystemic shunt for hepatitis B virus-related portal hypertension 11/13/2024 10:10:50 AM \| Browse: 142 \| Download: 476
24	Rifaximin discontinuation during broad-spectrum antibiotic treatment in critically ill patients with hepatic encephalopathy 11/6/2024 9:51:00 AM \| Browse: 146 \| Download: 512
25	Portocaval shunts' role in gut microbiota and hepatic encephalopathy: The gut-to-brain pathway 10/31/2024 10:42:49 AM \| Browse: 135 \| Download: 539
26	Predicting the risk of mortality in children with dengue-induced hepatitis admitted to the paediatric intensive care unit 10/31/2024 9:55:09 AM \| Browse: 144 \| Download: 625
27	Alterations in the gut microbiome after transjugular intrahepatic portosystemic shunt in patients with hepatitis B virus-related portal hypertension 8/13/2024 8:00:24 AM \| Browse: 134 \| Download: 834
28	Spleen volume is associated with overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with portal hypertension 7/22/2024 11:57:18 AM \| Browse: 124 \| Download: 863
29	Fecal microbiota transplantation in the treatment of hepatic encephalopathy: A perspective 5/22/2024 11:33:24 AM \| Browse: 119 \| Download: 515
30	Can rifaximin for hepatic encephalopathy be discontinued during broad-spectrum antibiotic treatment? 2/27/2024 11:58:45 AM \| Browse: 220 \| Download: 869
31	Role of fecal microbiota transplant in management of hepatic encephalopathy: Current trends and future directions 1/23/2024 9:31:44 AM \| Browse: 259 \| Download: 823
32	Evaluation of a protocol for rifaximin discontinuation in critically ill patients with liver disease receiving broad-spectrum antibiotic therapy 11/24/2023 6:10:12 AM \| Browse: 261 \| Download: 988
33	Prevention and treatment of hepatic encephalopathy during the perioperative period of transjugular intrahepatic portosystemic shunt 8/25/2023 12:08:22 PM \| Browse: 237 \| Download: 821
34	Intracranial pressure monitoring in the perioperative period of patients with acute liver failure undergoing orthotopic liver transplantation 6/16/2023 7:59:37 AM \| Browse: 285 \| Download: 700
35	Branched chain amino acids in hepatic encephalopathy and sarcopenia in liver cirrhosis: Evidence and uncertainties 5/16/2023 7:16:46 AM \| Browse: 270 \| Download: 791
36	Contributory roles of sarcopenia and myosteatosis in development of overt hepatic encephalopathy and mortality after transjugular intrahepatic portosystemic shunt 5/11/2023 8:05:04 AM \| Browse: 422 \| Download: 1180
37	Treatment of portosystemic shunt-borne hepatic encephalopathy in a 97-year-old woman using balloon-occluded retrograde transvenous obliteration: A case report 2/6/2023 6:38:44 AM \| Browse: 352 \| Download: 1070
38	Spontaneous remission of hepatic myelopathy in a patient with alcoholic cirrhosis: A case report 10/21/2022 2:24:59 AM \| Browse: 462 \| Download: 1303
39	Gut microbiota alteration and modulation in hepatitis B virus-related fibrosis and complications: Molecular mechanisms and therapeutic inventions 7/27/2022 2:48:53 AM \| Browse: 562 \| Download: 1378
40	Evidence-based approach to management of hepatic encephalopathy in adults 4/22/2022 10:52:23 AM \| Browse: 599 \| Download: 1119
41	Effect of a specific Escherichia coli Nissle 1917 strain on minimal/mild hepatic encephalopathy treatment 3/24/2022 2:13:21 PM \| Browse: 624 \| Download: 2179
42	Predictors of mortality at 28-days in infection associated acute kidney injury in cirrhosis 3/24/2022 2:13:21 PM \| Browse: 626 \| Download: 2191
43	Successful embolization of an intrahepatic portosystemic shunt using balloon-occluded retrograde transvenous obliteration: A case report 2/23/2022 3:51:55 PM \| Browse: 501 \| Download: 1304
44	Role of early transjugular intrahepatic portosystemic stent-shunt in acute variceal bleeding: An update of the evidence and future directions 11/25/2021 7:42:46 AM \| Browse: 535 \| Download: 1030
45	Simultaneous embolization of spontaneous porto-systemic shunts and intrahepatic arterioportal fistula: A case report 10/29/2021 12:16:54 PM \| Browse: 624 \| Download: 1739
46	Probiotics in hepatology: An update 9/22/2021 8:09:41 AM \| Browse: 791 \| Download: 1808
47	Neurological and psychiatric effects of hepatitis C virus infection 8/4/2021 7:56:20 AM \| Browse: 804 \| Download: 1855
48	Long-term albumin infusion in decompensated cirrhosis: A review of current literature 4/16/2021 10:13:42 AM \| Browse: 710 \| Download: 1630
49	Comparative study of the indocyanine green-R15, Child-Pugh score and model for end-stage liver disease score for the prediction of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt 1/29/2021 7:57:41 AM \| Browse: 765 \| Download: 2039
50	Role of ammonia in predicting the outcome of patients with acute-on-chronic liver failure 1/20/2021 12:47:16 PM \| Browse: 572 \| Download: 1483

Page 1 of 2 ( 100 items )
<<
1
2
>>

1	Minimal hepatic encephalopathy in hepatosplenic schistosomiasis: High prevalence and association with portosystemic shunts in a Brazilian cross-sectional study 12/26/2025 10:27:29 AM \| Browse: 15 \| Download: 88
2	Targeting gut microbiota in liver disease: A pharmacological approach for hepatic encephalopathy and beyond 12/5/2025 11:28:03 AM \| Browse: 25 \| Download: 84
3	Elevated body mass index as a prognostic marker in acute liver failure: Implications from a two-decade cohort 12/5/2025 6:43:30 AM \| Browse: 23 \| Download: 70
4	Management of acute liver failure-an updated literature review 11/28/2025 2:00:44 PM \| Browse: 28 \| Download: 75
5	Improved clinical outcomes following embolization of extrahepatic portosystemic shunts in cirrhotic patients with recurrent hepatic encephalopathy 10/27/2025 10:57:51 AM \| Browse: 144 \| Download: 163
6	Microbiome and gut-liver interactions: From mechanisms to therapies 10/27/2025 8:08:12 AM \| Browse: 107 \| Download: 131
7	Body mass index and its association with clinical outcomes in acute liver failure 10/11/2025 9:30:02 AM \| Browse: 38 \| Download: 116
8	Critical flicker frequency improves after alcohol detoxification and is associated with liver stiffness 9/19/2025 7:57:22 AM \| Browse: 324 \| Download: 87
9	Paradigm shifts in hepatic encephalopathy: A review of recent therapeutic breakthroughs 9/10/2025 8:40:29 AM \| Browse: 296 \| Download: 107
10	Risk factors for hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in cirrhotic patients: A comprehensive minireview 8/27/2025 9:21:14 AM \| Browse: 165 \| Download: 230
11	Modulating nuclear factor erythroid 2-related factor 2 and heme oxygenase-1 in liver-brain axis disorders 8/26/2025 10:18:28 AM \| Browse: 73 \| Download: 132
12	Acute liver failure etiology, clinical manifestation and outcomes in adults: Experience of tertiary care hospital in Karachi 7/18/2025 3:29:25 PM \| Browse: 57 \| Download: 368
13	Human albumin infusion for reducing hyponatremia and circulatory dysfunction in liver cirrhosis: A meta-analysis update 6/26/2025 7:27:59 AM \| Browse: 59 \| Download: 492
14	Importance of comprehensive nutritional assessment in predicting survival in cirrhosis 5/27/2025 7:04:45 AM \| Browse: 7 \| Download: 12
15	Incidence and efficacy of strategies for preventing hepatic encephalopathy following transjugular intrahepatic portosystemic shunt: A meta-analysis 4/25/2025 8:23:03 AM \| Browse: 74 \| Download: 341
16	Management of hepatic encephalopathy following transjugular intrahepatic portosystemic shunts: Current strategies and future directions 4/18/2025 7:43:23 AM \| Browse: 144 \| Download: 460
17	Effect of portal pressure gradient reduction on outcomes after transjugular intrahepatic portosystemic shunt in portal hypertension patients 3/26/2025 4:06:57 AM \| Browse: 86 \| Download: 591
18	Dysregulation of bile acid signal transduction causes neurological dysfunction in cirrhosis rats 3/26/2025 4:06:51 AM \| Browse: 72 \| Download: 530
19	Clinical features and risk factors for combined Klebsiella pneumoniae infection in patients with liver cirrhosis 2/20/2025 8:40:36 AM \| Browse: 101 \| Download: 386
20	Which patients benefit the most? An update on transjugular intrahepatic portosystemic shunt 2/20/2025 8:39:23 AM \| Browse: 90 \| Download: 424
21	Gut microbiome composition in patients with liver cirrhosis with and without hepatic encephalopathy: A systematic review and meta-analysis 1/6/2025 8:47:54 AM \| Browse: 77 \| Download: 562
22	Gut microbiota shifts in hepatitis B-related portal hypertension after transjugular intrahepatic portosystemic shunt: Mechanistic and clinical implications 12/20/2024 3:53:46 AM \| Browse: 145 \| Download: 641
23	Insights and future directions in studying intestinal microbiota post-transjugular intrahepatic portosystemic shunt for hepatitis B virus-related portal hypertension 11/13/2024 10:10:50 AM \| Browse: 142 \| Download: 476
24	Rifaximin discontinuation during broad-spectrum antibiotic treatment in critically ill patients with hepatic encephalopathy 11/6/2024 9:51:00 AM \| Browse: 146 \| Download: 512
25	Portocaval shunts' role in gut microbiota and hepatic encephalopathy: The gut-to-brain pathway 10/31/2024 10:42:49 AM \| Browse: 135 \| Download: 539
26	Predicting the risk of mortality in children with dengue-induced hepatitis admitted to the paediatric intensive care unit 10/31/2024 9:55:09 AM \| Browse: 144 \| Download: 625
27	Alterations in the gut microbiome after transjugular intrahepatic portosystemic shunt in patients with hepatitis B virus-related portal hypertension 8/13/2024 8:00:24 AM \| Browse: 134 \| Download: 834
28	Spleen volume is associated with overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with portal hypertension 7/22/2024 11:57:18 AM \| Browse: 124 \| Download: 863
29	Fecal microbiota transplantation in the treatment of hepatic encephalopathy: A perspective 5/22/2024 11:33:24 AM \| Browse: 119 \| Download: 515
30	Can rifaximin for hepatic encephalopathy be discontinued during broad-spectrum antibiotic treatment? 2/27/2024 11:58:45 AM \| Browse: 220 \| Download: 869
31	Role of fecal microbiota transplant in management of hepatic encephalopathy: Current trends and future directions 1/23/2024 9:31:44 AM \| Browse: 259 \| Download: 823
32	Evaluation of a protocol for rifaximin discontinuation in critically ill patients with liver disease receiving broad-spectrum antibiotic therapy 11/24/2023 6:10:12 AM \| Browse: 261 \| Download: 988
33	Prevention and treatment of hepatic encephalopathy during the perioperative period of transjugular intrahepatic portosystemic shunt 8/25/2023 12:08:22 PM \| Browse: 237 \| Download: 821
34	Intracranial pressure monitoring in the perioperative period of patients with acute liver failure undergoing orthotopic liver transplantation 6/16/2023 7:59:37 AM \| Browse: 285 \| Download: 700
35	Branched chain amino acids in hepatic encephalopathy and sarcopenia in liver cirrhosis: Evidence and uncertainties 5/16/2023 7:16:46 AM \| Browse: 270 \| Download: 791
36	Contributory roles of sarcopenia and myosteatosis in development of overt hepatic encephalopathy and mortality after transjugular intrahepatic portosystemic shunt 5/11/2023 8:05:04 AM \| Browse: 422 \| Download: 1180
37	Treatment of portosystemic shunt-borne hepatic encephalopathy in a 97-year-old woman using balloon-occluded retrograde transvenous obliteration: A case report 2/6/2023 6:38:44 AM \| Browse: 352 \| Download: 1070
38	Spontaneous remission of hepatic myelopathy in a patient with alcoholic cirrhosis: A case report 10/21/2022 2:24:59 AM \| Browse: 462 \| Download: 1303
39	Gut microbiota alteration and modulation in hepatitis B virus-related fibrosis and complications: Molecular mechanisms and therapeutic inventions 7/27/2022 2:48:53 AM \| Browse: 562 \| Download: 1378
40	Evidence-based approach to management of hepatic encephalopathy in adults 4/22/2022 10:52:23 AM \| Browse: 599 \| Download: 1119
41	Effect of a specific Escherichia coli Nissle 1917 strain on minimal/mild hepatic encephalopathy treatment 3/24/2022 2:13:21 PM \| Browse: 624 \| Download: 2179
42	Predictors of mortality at 28-days in infection associated acute kidney injury in cirrhosis 3/24/2022 2:13:21 PM \| Browse: 626 \| Download: 2191
43	Successful embolization of an intrahepatic portosystemic shunt using balloon-occluded retrograde transvenous obliteration: A case report 2/23/2022 3:51:55 PM \| Browse: 501 \| Download: 1304
44	Role of early transjugular intrahepatic portosystemic stent-shunt in acute variceal bleeding: An update of the evidence and future directions 11/25/2021 7:42:46 AM \| Browse: 535 \| Download: 1030
45	Simultaneous embolization of spontaneous porto-systemic shunts and intrahepatic arterioportal fistula: A case report 10/29/2021 12:16:54 PM \| Browse: 624 \| Download: 1739
46	Probiotics in hepatology: An update 9/22/2021 8:09:41 AM \| Browse: 791 \| Download: 1808
47	Neurological and psychiatric effects of hepatitis C virus infection 8/4/2021 7:56:20 AM \| Browse: 804 \| Download: 1855
48	Long-term albumin infusion in decompensated cirrhosis: A review of current literature 4/16/2021 10:13:42 AM \| Browse: 710 \| Download: 1630
49	Comparative study of the indocyanine green-R15, Child-Pugh score and model for end-stage liver disease score for the prediction of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt 1/29/2021 7:57:41 AM \| Browse: 765 \| Download: 2039
50	Role of ammonia in predicting the outcome of patients with acute-on-chronic liver failure 1/20/2021 12:47:16 PM \| Browse: 572 \| Download: 1483